Consistently, biomarkers of endothelial dysfunction, such as thrombomodulin, VWF, angiopoietin 2, and plasminogen activator inhibitor-1, are frequently elevated, and seem to be associated with disease severity in COVID-19 patients [117,118]. Here, THBD is linked to COVID-19.